FDA Approves First Generic Propofol Injectable Emulsion for Dogs
November 18, 2024
Today the U.S. Food and Drug Administration approved PropofolVet Multidose, the first generic propofol injectable emulsion for dogs. PropofolVet Multidose is approved for use as an injectable anesthetic in dogs.
PropofolVet Multidose contains the same active ingredient (propofol injectable emulsion) as the approved brand name drug product, PropoFlo 28, which was first approved on February 4, 2011. In addition, the FDA determined that PropofolVet Multidose contains no inactive ingredients that may significantly affect the bioavailability of the active ingredient.
PropofolVet Multidose is supplied in a 10 mg/mL concentration in 20mL multidose vials.
PropofolVet Multidose is sponsored by Parnell Technologies Pty. Ltd. based in New South Wales, Australia.
For more information:
Issued by FDA Center for Veterinary Medicine.
For questions, Contact CVM.